ratiopharm GmbH - Strategic SWOT Analysis Review

  • July 2014
  • -
  • Global Data
  • -
  • 19 pages

ratiopharm GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

ratiopharm GmbH (ratiopharm) is a pharmaceutical company. It develops, manufactures and sells generic medicines and biosimilars. The company's product portfolio comprises prescription (ethical) and non-prescription preparations (OTC) products which include creams, tablets, suppositories, ampoules, ointment and liquids. It produces medicines in the therapeutic areas of skin diseases, asthma, arthritis, bronchitis, cardiovascular diseases, diabetes and cancer with tumor blockers and immune modifiers. Some of its brands include AZ Complex, Acarbose, Ace inhibitor, Aciclovir, Allopurinol and Amantidine.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

ratiopharm GmbH - Strategic SWOT Analysis Review
Table of Contents



Section 1 - About the Company 5
ratiopharm GmbH - Key Facts 5
ratiopharm GmbH - Key Employees 6
ratiopharm GmbH - Major Products and Services 7
ratiopharm GmbH - History 8
ratiopharm GmbH - Locations And Subsidiaries 9
Head Office 9
Other Locations and Subsidiaries 9
Section 2 - Company Analysis 10
ratiopharm GmbH - Business Description 10
ratiopharm GmbH - Corporate Strategy 11
ratiopharm GmbH - SWOT Analysis 12
SWOT Analysis - Overview 12
ratiopharm GmbH - Strengths 12
Strength - Broad Range of Products 12
Strength - Strong Manufacturing Capabilities 12
ratiopharm GmbH - Weaknesses 12
Weakness - Dependency on German Market 12
ratiopharm GmbH - Opportunities 12
Opportunity - Patent Expirations of Blockbuster Drugs 12
Opportunity - Strategic Initiatives 13
Opportunity - Rising Market for Generics 13
ratiopharm GmbH - Threats 13
Threat - Growing Parallel Trade 13
Threat - Increasing Competition 13
Threat - Stringent Government Regulations 14
ratiopharm GmbH - Key Competitors 15
Section 3 - Company's Lifesciences Financial Deals and Alliances 16
ratiopharm GmbH, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 16
ratiopharm GmbH, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 17
ratiopharm GmbH, Recent Deals Summary 18
Section 4 - Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables

ratiopharm GmbH, Key Facts 5
ratiopharm GmbH, Key Employees 6
ratiopharm GmbH, Major Products and Services 7
ratiopharm GmbH, History 8
ratiopharm GmbH, Subsidiaries 9
ratiopharm GmbH, Key Competitors 15
ratiopharm GmbH, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 16
ratiopharm GmbH, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 17
ratiopharm GmbH, Recent Deals Summary 18

List of Figures

ratiopharm GmbH, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 16
ratiopharm GmbH, Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 17

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Oncgnostics GmbH - Product Pipeline Analysis, 2015 Update

Oncgnostics GmbH - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • February 2015
  • by Global Data

Summary Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company. It is involved in developing molecular in vitro diagnostic (IVD) tests for screening, follow-up care and therapeutic decisions ...

Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

Orion Genomics LLC - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Orion Genomics LLC (Orion Genomics) is a provider of epigenetic research tools and molecular diagnostic products. Its products include colon cancer risk test, bladder cancer screening and lung ...

Vitatex Inc. - Product Pipeline Analysis, 2014 Update

Vitatex Inc. - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Vitatex Inc. (Vitatex) is a biotechnology company. The company research and develops new immunochemistry assays and reagents for the in-vitro diagnostic market. Its research products include Vita-Assays, ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.